N/A N=63 Randomized Quadruple-blind Treatment

Treatment of Androgenetic Alopecia in Females, 12 Beam

Androgenetic Alopecia · Hair Loss · Female Pattern Baldness

Bottom Line

View on ClinicalTrials.gov: NCT01016964 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Sep 2012

Primary outcome: Primary: Change in Hair Count at 16 and 26 Weeks Over Baseline — -0.8; 12.5; 3.0; 20.6 hairs per cm^2

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: HairMax LaserComb 2009 model 12 beam (Device); Sham Device (Device)
Age: Adult · 25+ yrs
Sex: Female
Sponsor: Lexington International, LLC
Primary completion: Mar 2011

Outcome Measures

Outcome	Result	p-value
PRIMARY Change in Hair Count at 16 and 26 Weeks Over Baseline	-0.8; 12.5; 3.0; 20.6	—

Summary

The purpose of this study is to evaluate the efficacy of the HairMax LaserComb 2009 12 beam model for androgenetic alopecia in females when treatment is applied as directed.

Eligibility Criteria

Inclusion Criteria

Diagnosis of androgenetic alopecia
Fitzpatrick Skin types I-IV
Ludwig I-4, II-1, II-2, or frontal
Active hair loss within last 12 months

Exclusion Criteria

Photosensitivity to laser light
Malignancy in the target area
Pregnancy
Lactating females

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01016964). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.